PrimeRFP SCOUT · Federal Contract Profile

Partner Therapeutics (J33MSDBJZMC6)Federal contracts · 1 recompete

Partner Therapeutics holds $147.4M in federal volume across 9 award actions, with 100% at Department of Health and Human Services (HHS). SCOUT tracks 1 incumbent recompete — an estimated $133.5M returning to market over the next 24 months (High exposure). Primary work: Pharmaceutical Preparation; Research And Development In (100% prime). Obligations are up 11% year over year.

$147.4M
Federal Volume
1
Recompetes (24mo)
HHS
Top Agency · 100% firm-wide
9
Award Actions

Choose one — this changes what we ask next

Score my firm against Partner Therapeutics

Email me when a Partner Therapeutics recompete window opens.

Data through · refreshed monthly · window Aug 2025 – Aug 2026
What they do

Capability

Service lines

PHARMACEUTICAL PREPARATION MANUFACTURING · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)

Work mix: 100% prime · 0% sub · primary NAICS 325412 / PSC 6515 MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES

Where they win

2 agencies
% of firm-wide obligated ($147.4M) · all agencies

Recompete exposure: High · 1 in 24mo

Partner Therapeutics has an estimated $133.5M in contracts returning to market over the next 24 months.

Recompete exposure & trajectory

Recompete exposure

High

Partner Therapeutics has an estimated $133.5M in contracts returning to market over the next 24 months.

Trajectory
Expanding+11% YoYFY2025 vs FY2024
'23
'24
'25
SCOUT saves the hours of analysis that capture and proposal teams cannot afford to lose by delivering analyzed intelligence. Incumbent history, competitive positioning, and agency buying patterns get synthesized into…
Gwyne Taylor, Tailored Global
Explore another company
Don’t see your company?

Enter your company name and we'll build the page.

Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →

Frequently asked questions

What federal contracts does Partner Therapeutics hold?

Partner Therapeutics (UEI J33MSDBJZMC6) shows $147.4M across 9 award actions in SCOUT’s public USASpending-backed profile, with Department of Health and Human Services (HHS) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.

How much in federal contracts does Partner Therapeutics have?

Partner Therapeutics shows $147.4M across 9 award actions. SCOUT tracks 1 incumbent recompetes ($133.5M) returning to market in the next 24 months.

Which agencies does Partner Therapeutics work with?

Partner Therapeutics’s firm-wide obligated mix is led by Department of Health and Human Services (HHS) (100%), Department of Veterans Affairs (VA) (0%).

What is the UEI for Partner Therapeutics?

The Unique Entity ID (UEI) for Partner Therapeutics is J33MSDBJZMC6.

Does Partner Therapeutics have contracts coming up for recompete?

Yes — SCOUT tracks 1 incumbent recompete in the next 24 months (High exposure). Open the recompete section on this page for PIID-level timing.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Sources: USASpending, FPDS, SAM.gov · Data shown is public-record; analysis by PrimeRFP SCOUT. Corpus refreshed Aug 20, 2026. Profile snapshot Aug 19, 2026.
primerfp.com/intel/company/partner-therapeutics-inc